HARVARD BIOSCIENCE INC — Director's Dealing 2021

Jan 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2020-12-31

Reporting Person: Green James W (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-31	Common Stock	F	26231	$4.29	Disposed	1963884	Direct
2021-01-01	Common Stock	F	30478	$4.29	Disposed	1933406	Direct

Footnotes

F1: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person which vested in part on December 31, 2020.

F2: Includes (a) 163,606 remaining restricted stock units that will vest on December 31, 2021, 2022 and 2023; (b) 243,072 restricted stock units that will fully vest on July 8, 2021; (c) 209,180 restricted stock units that will vest on January 1, 2022 and 2023; (d) 636,502 restricted stock units with performance based vesting conditions tied to relative total shareholder return; and (e) 711,524 shares of common stock beneficially owned by the Reporting Person.

F3: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person which vested in part on January 1, 2021.

F4: Includes (a) the shares and awards described in footnote (2) above, less (b) the disposition of shares reported in footnote (3) above.